Resistance analysis of genotype 3 hepatitis C virus indicates subtypes inherently resistant to nonstructural protein 5A inhibitors
Hepatitis C virus (HCV) genotype (gt) 3 is highly prevalent globally, with non‐gt3a subtypes common in Southeast Asia. Resistance‐associated substitutions (RASs) have been shown to play a role in treatment failure. However, the role of RASs in gt3 is not well understood. We report the prevalence of...
Autors principals: | Smith, D, Magri, A, Bonsall, D, Ip, C, Trebes, A, Brown, A, Piazza, P, Bowden, R, Nguyen, D, STOP-HCV Consortium, Ansari, M, Simmonds, P, Barnes, E |
---|---|
Format: | Journal article |
Publicat: |
American Association for the Study of Liver Diseases
2018
|
Ítems similars
-
Comparison of next generation sequencing technologies for the comprehensive assessment of full-length hepatitis C viral genomes
per: Ip, C, et al.
Publicat: (2016) -
Efficacy of NS5A inhibitors against unusual and potentially difficult-to-treat HCV subtypes commonly found in sub Saharan Africa and South East Asia
per: Nguyen, D, et al.
Publicat: (2020) -
ve-SEQ: Robust, unbiased enrichment for streamlined detection and whole-genome sequencing of HCV and other highly diverse pathogens
per: Bowden, R, et al.
Publicat: (2015) -
Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus
per: Ansari, M, et al.
Publicat: (2017) -
Impact of IFNL4 genotype on interferon-stimulated gene expression during daa therapy for Hepatitis C
per: Ramamurthy, N, et al.
Publicat: (2018)